Session 3: What does ‘phase-appropriate’ actually look like in early process and product development?

Name: Session 3: What does ‘phase-appropriate’ actually look like in early process and product development?
Start: 2027-01-19T15:00
End: 2027-01-19T16:00
Location: San Diego Convention Center

Advanced Therapies Week 2027 · 19 January 2027 · 15:00–16:00 · Theatre 1

Session 3: What does ‘phase-appropriate’ actually look like in early process and product development? was a session at Advanced Therapies Week 2027 on 19 January 2027 in San Diego, with 5 speakers on record.

Speakers

Donna Rill — Speaker Chief Technology Officer, Triumvira Immunologics
Tatiana Nanda — Speaker CTO, SK Pharmteco
Noah Davidsohn — Speaker CSO and Co-founder, Rejuvenate Bio
Adam Fung — Speaker Sr Director, Global Product Quality, Iovance Biotherapeutics
Alison Burkart — Speaker Director, Astellas Pharma